Skip to main content

Advertisement

SpringerLink
Log in

Long-term outcome of acute and subacute myelopathies

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

We aimed to evaluate the long-term (>2 years) outcome of acute and subacute myelopathies (ASM). We systematically followed-up consecutive patients presenting with a first episode of ASM, defined by spinal cord symptoms with an onset <3 weeks and duration ≥48 h. Patients with compressive or traumatic spinal cord lesions are excluded from this report. Our cohort consisted of 170 patients (median age 39.0 years, median duration of follow-up 73.2 months). The death rate was 8.8%, Lipton and Teasdall’s functional score was bad or fair in 38.2%, and 37.1% of the survivors who worked when the ASM occurred were unable to carry on with the same profession. Unfavorable functional outcome was more frequent when (1) symptoms were initially severe, (2) the lesion was located centrally on spinal cord MRI and (3) the etiology was neuromyelitis optica (NMO) or systemic disease (SD). In one-third of patients the etiology at the end of follow-up differed from the etiology suspected after the initial diagnostic workup. Over half of patients initially diagnosed with myelopathy of undetermined cause subsequently developed multiple sclerosis, NMO or SD. ASM is a severe condition with a bad or fair functional outcome and a major impact on professional activity in one-third of the patients. Central lesions on spinal cord MRI and etiologies such as NMO or SD are associated with a worse functional outcome. Finally, a long-term follow-up is important given the large number of causes that are identified at a distance from the initial event.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059–2069

    Article  PubMed  Google Scholar 

  2. Baughman RP, Lower EE, du Bois RM (2003) Sarcoidosis. Lancet 361:1111–1118

    Article  PubMed  CAS  Google Scholar 

  3. Berman M, Feldman S, Alter M, Zilber N, Kahana E (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966–971

    PubMed  CAS  Google Scholar 

  4. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E, Ader HJ, Castelijns JA (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226–233

    PubMed  CAS  Google Scholar 

  5. Breteau G, Stojkovic T, De Seze J, Gauvrit J, Pruvo J, Vermersch P (2000) Adenovirus et Epstein-Barr virus: deux étiologies rares au profil identique. Rev Neurol Paris 156:786–789

    PubMed  CAS  Google Scholar 

  6. Catz A, Goldin D, Fishel B, Ronen J, Bluvshtein V, Gelernter I (2004) Recovery of neurologic function following nontraumatic spinal cord lesions in Israel. Spine 29:2278–2282 discussion 2283

    Article  PubMed  Google Scholar 

  7. Cheshire WP, Santos CC, Massey EW, Howard JF Jr (1996) Spinal cord infarction: etiology and outcome. Neurology 47:321–330

    PubMed  CAS  Google Scholar 

  8. Christensen PB, Wermuth L, Hinge HH, Bomers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 81:431–435

    Article  PubMed  CAS  Google Scholar 

  9. Citterio A, Franceschini M, Spizzichino L, Reggio A, Rossi B, Stampacchia G (2004) Nontraumatic spinal cord injury: an Italian survey. Arch Phys Med Rehabil 85:1483–1487

    Article  PubMed  Google Scholar 

  10. Cordonnier C, de Seze J, Breteau G, Ferriby D, Michelin E, Stojkovic T, Pruvo JP, Vermersch P (2003) Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 250:1447–1452

    Article  PubMed  CAS  Google Scholar 

  11. Dalecky A, Pelletier J, Cherif AA, Levrier O, Khalil R (1997) Acute myelopathies in young patients and multiple sclerosis. Prospective study of 20 cases. Rev Neurol (Paris) 153:569–578

    Google Scholar 

  12. de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953

    Article  PubMed  Google Scholar 

  13. de Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, Hachulla E, Mounier-Vehier F, Pruvo JP, Leys D, Destee A, Hatron PY, Vermersch P (2001) Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124:1509–1521

    Article  PubMed  Google Scholar 

  14. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P (2002) Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57–61

    Article  PubMed  Google Scholar 

  15. de Seze J, Stojkovic T, Hachulla E, Breteau G, Michon-Pasturel U, Mounier-Vehier F, Hatron PY, Vermersch P (2001) Myélopathies et syndrome de Gougerot-Sjögren: étude clinique, radiologique et profil évolutif. Rev Neurol (Paris) 157:669–678

    Google Scholar 

  16. Debette S, Gauvrit JY, Desseaux G, Nibbio A, Henon H, Pruvo JP, Leys D (2003) Paraplegia after ligation of esophageal varices. Neurology 60:879–880

    PubMed  CAS  Google Scholar 

  17. Farkkila M, Tiainen T, Koskiniemi M (1997) Epidemiology and prognosis of acute myelitis in Southern Finland. J Neurol Sci 152:140–146

    Article  PubMed  CAS  Google Scholar 

  18. Ford B, Tampieri D, Francis G (1992) Long-term follow-up of acute partial transverse myelopathy. Neurology 42:250–252

    PubMed  CAS  Google Scholar 

  19. Henon H, Vermersch P, Dutoit E, Dubois F, Camus D, Petit H (1995) Myelite a anguillule. Rev Neurol (Paris) 151:139–141

    CAS  Google Scholar 

  20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  21. Iseli E, Cavigelli A, Dietz V, Curt A (1999) Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry 67:567–571

    Article  PubMed  CAS  Google Scholar 

  22. Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535

    PubMed  CAS  Google Scholar 

  23. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, McDonald WI, Miller DH (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43:2632–2637

    PubMed  CAS  Google Scholar 

  24. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59:120–124

    Article  PubMed  CAS  Google Scholar 

  25. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107

    PubMed  CAS  Google Scholar 

  26. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112

    Article  PubMed  CAS  Google Scholar 

  27. Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 28:252–257

    PubMed  CAS  Google Scholar 

  28. Lu X, Gu Y, Wang Y, Chen S, Ye S (2008) Prognostic factors of lupus myelopathy. Lupus 17:323–328

    Article  PubMed  CAS  Google Scholar 

  29. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125:1450–1461

    Article  PubMed  Google Scholar 

  30. Mandler RN (2006) Neuromyelitis optica—Devic’s syndrome, update. Autoimmun Rev 5:537–543

    Article  PubMed  Google Scholar 

  31. Masson C, Pruvo JP, Meder JF, Cordonnier C, Touze E, De La Sayette V, Giroud M, Mas JL, Leys D (2004) Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 75:1431–1435

    Article  PubMed  CAS  Google Scholar 

  32. Maynard FM Jr, Bracken MB, Creasey G, Ditunno JF Jr, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W (1997) International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord 35:266–274

    Article  PubMed  Google Scholar 

  33. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    Article  PubMed  CAS  Google Scholar 

  34. McKinley WO, Seel RT, Hardman JT (1999) Nontraumatic spinal cord injury: incidence, epidemiology, and functional outcome. Arch Phys Med Rehabil 80:619–623

    Article  PubMed  CAS  Google Scholar 

  35. Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635–639

    Article  PubMed  CAS  Google Scholar 

  36. Mok CC, Lau CS, Chan EY, Wong RW (1998) Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 25:467–473

    PubMed  CAS  Google Scholar 

  37. Nedeltchev K, Loher TJ, Stepper F, Arnold M, Schroth G, Mattle HP, Sturzenegger M (2004) Long-term outcome of acute spinal cord ischemia syndrome. Stroke 35:560–565

    Article  PubMed  Google Scholar 

  38. O’Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387

    Article  PubMed  Google Scholar 

  39. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  40. Pradhan S, Gupta RK, Ghosh D (1997) Parainfectious myelitis: three distinct clinico-imagiological patterns with prognostic implications. Acta Neurol Scand 95:241–247

    Article  PubMed  CAS  Google Scholar 

  41. Provenzale JM, Barboriak DP, Gaensler EH, Robertson RL, Mercer B (1994) Lupus-related myelitis: serial MR findings. AJNR Am J Neuroradiol 15:1911–1917

    PubMed  CAS  Google Scholar 

  42. Ramirez C, de Seze J, Delalande S, Michelin E, Ferriby D, Al Khedr A, Stojkovic T, Destee A, Vermersch P (2004) Myelopathies infectieuses: profils cliniques, paracliniques et evolutifs. Rev Neurol (Paris) 160:1048–1058

    CAS  Google Scholar 

  43. Ronen J, Goldin D, Bluvshtein V, Fishel B, Gelernter I, Catz A (2004) Survival after nontraumatic spinal cord lesions in Israel. Arch Phys Med Rehabil 85:1499–1502

    Article  PubMed  Google Scholar 

  44. Salvador de la Barrera S, Barca-Buyo A, Montoto-Marques A, Ferreiro-Velasco ME, Cidoncha-Dans M, Rodriguez-Sotillo A (2001) Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord 39:520–525

    Google Scholar 

  45. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ, Tan EM, Tan EM (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus special antibodies for the study of systemic lupus erythematosus: an analysis autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  46. Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M (1995) Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195:725–732

    PubMed  CAS  Google Scholar 

  47. Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505

    Google Scholar 

  48. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  49. Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60:848–853

    PubMed  Google Scholar 

  50. Zaffaroni M (2004) Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol Sci 25(Suppl 4):S368–S370

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University Hospital of Lille, Hôpital Roger Salengro, CHRU de Lille, 59037, Lille, France

    S. Debette, J. de Sèze, H. Zephir, F. Pasquier, D. Leys & P. Vermersch

  2. Department of Neuroradiology, University Hospital of Lille, Lille, France

    J.-P. Pruvo

  3. Department of Neurology, University Hospital of Strasbourg, Strasbourg, France

    J. de Sèze

Authors
  1. S. Debette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. de Sèze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.-P. Pruvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Zephir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Pasquier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Leys
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Vermersch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Vermersch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debette, S., de Sèze, J., Pruvo, JP. et al. Long-term outcome of acute and subacute myelopathies. J Neurol 256, 980–988 (2009). https://doi.org/10.1007/s00415-009-5058-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5058-x

Keywords

Search

Navigation